vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and Karat Packaging Inc. (KRT). Click either name above to swap in a different company.

Core Laboratories Inc. is the larger business by last-quarter revenue ($121.8M vs $115.6M, roughly 1.1× Karat Packaging Inc.). Karat Packaging Inc. runs the higher net margin — 5.9% vs 4.2%, a 1.7% gap on every dollar of revenue. On growth, Karat Packaging Inc. posted the faster year-over-year revenue change (13.7% vs -1.4%). Karat Packaging Inc. produced more free cash flow last quarter ($15.1M vs $517.0K). Over the past eight quarters, Karat Packaging Inc.'s revenue compounded faster (10.0% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Karat Packaging Inc. is a specialty manufacturer and distributor of disposable foodservice packaging products. Its offerings include paper and plastic cups, food containers, cutlery, lids, and custom branded solutions, serving restaurant chains, cafes, catering operators, and retail foodservice clients primarily across North America.

CLB vs KRT — Head-to-Head

Bigger by revenue
CLB
CLB
1.1× larger
CLB
$121.8M
$115.6M
KRT
Growing faster (revenue YoY)
KRT
KRT
+15.2% gap
KRT
13.7%
-1.4%
CLB
Higher net margin
KRT
KRT
1.7% more per $
KRT
5.9%
4.2%
CLB
More free cash flow
KRT
KRT
$14.6M more FCF
KRT
$15.1M
$517.0K
CLB
Faster 2-yr revenue CAGR
KRT
KRT
Annualised
KRT
10.0%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLB
CLB
KRT
KRT
Revenue
$121.8M
$115.6M
Net Profit
$5.1M
$6.8M
Gross Margin
34.0%
Operating Margin
1.5%
7.3%
Net Margin
4.2%
5.9%
Revenue YoY
-1.4%
13.7%
Net Profit YoY
21.3%
EPS (diluted)
$0.11
$0.34

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
KRT
KRT
Q1 26
$121.8M
Q4 25
$138.3M
$115.6M
Q3 25
$134.5M
$124.5M
Q2 25
$130.2M
$124.0M
Q1 25
$123.6M
$103.6M
Q4 24
$129.2M
$101.6M
Q3 24
$134.4M
$112.8M
Q2 24
$130.6M
$112.6M
Net Profit
CLB
CLB
KRT
KRT
Q1 26
$5.1M
Q4 25
$4.9M
$6.8M
Q3 25
$14.2M
$7.3M
Q2 25
$10.6M
$10.9M
Q1 25
$-154.0K
$6.4M
Q4 24
$7.4M
$5.6M
Q3 24
$11.7M
$9.1M
Q2 24
$9.0M
$9.1M
Gross Margin
CLB
CLB
KRT
KRT
Q1 26
Q4 25
20.8%
34.0%
Q3 25
22.0%
34.5%
Q2 25
20.3%
39.6%
Q1 25
19.5%
39.3%
Q4 24
17.8%
39.2%
Q3 24
20.5%
38.6%
Q2 24
21.2%
38.5%
Operating Margin
CLB
CLB
KRT
KRT
Q1 26
1.5%
Q4 25
11.5%
7.3%
Q3 25
15.6%
6.9%
Q2 25
11.7%
13.3%
Q1 25
3.6%
7.5%
Q4 24
11.0%
7.2%
Q3 24
14.7%
10.0%
Q2 24
12.3%
9.9%
Net Margin
CLB
CLB
KRT
KRT
Q1 26
4.2%
Q4 25
3.6%
5.9%
Q3 25
10.6%
5.9%
Q2 25
8.2%
8.8%
Q1 25
-0.1%
6.2%
Q4 24
5.7%
5.5%
Q3 24
8.7%
8.1%
Q2 24
6.9%
8.1%
EPS (diluted)
CLB
CLB
KRT
KRT
Q1 26
$0.11
Q4 25
$0.11
$0.34
Q3 25
$0.30
$0.36
Q2 25
$0.22
$0.54
Q1 25
$0.00
$0.32
Q4 24
$0.15
$0.28
Q3 24
$0.25
$0.45
Q2 24
$0.19
$0.45

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
KRT
KRT
Cash + ST InvestmentsLiquidity on hand
$22.8M
$37.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$275.1M
$149.4M
Total Assets
$587.7M
$287.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
KRT
KRT
Q1 26
$22.8M
Q4 25
$22.7M
$37.9M
Q3 25
$25.6M
$44.0M
Q2 25
$31.2M
$57.0M
Q1 25
$22.1M
$56.3M
Q4 24
$19.2M
$59.9M
Q3 24
$21.5M
$60.4M
Q2 24
$17.7M
$52.1M
Total Debt
CLB
CLB
KRT
KRT
Q1 26
Q4 25
$110.3M
Q3 25
$114.1M
Q2 25
$124.6M
Q1 25
$124.4M
Q4 24
$126.1M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
CLB
CLB
KRT
KRT
Q1 26
$275.1M
Q4 25
$266.0M
$149.4M
Q3 25
$271.3M
$154.5M
Q2 25
$261.3M
$155.8M
Q1 25
$253.4M
$153.3M
Q4 24
$246.6M
$155.6M
Q3 24
$250.7M
$157.3M
Q2 24
$240.3M
$157.7M
Total Assets
CLB
CLB
KRT
KRT
Q1 26
$587.7M
Q4 25
$584.0M
$287.7M
Q3 25
$591.4M
$302.8M
Q2 25
$602.1M
$321.0M
Q1 25
$591.5M
$312.2M
Q4 24
$585.1M
$294.5M
Q3 24
$600.5M
$306.8M
Q2 24
$597.8M
$310.7M
Debt / Equity
CLB
CLB
KRT
KRT
Q1 26
Q4 25
0.41×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
KRT
KRT
Operating Cash FlowLast quarter
$4.0M
$15.4M
Free Cash FlowOCF − Capex
$517.0K
$15.1M
FCF MarginFCF / Revenue
0.4%
13.1%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
0.77×
2.26×
TTM Free Cash FlowTrailing 4 quarters
$22.5M
$33.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
KRT
KRT
Q1 26
$4.0M
Q4 25
$7.9M
$15.4M
Q3 25
$8.5M
$982.0K
Q2 25
$13.9M
$9.8M
Q1 25
$6.7M
$7.7M
Q4 24
$20.6M
$8.3M
Q3 24
$13.1M
$19.5M
Q2 24
$17.1M
$13.7M
Free Cash Flow
CLB
CLB
KRT
KRT
Q1 26
$517.0K
Q4 25
$5.0M
$15.1M
Q3 25
$6.5M
$736.0K
Q2 25
$10.4M
$9.6M
Q1 25
$3.9M
$7.6M
Q4 24
$17.4M
$8.0M
Q3 24
$10.4M
$19.2M
Q2 24
$14.3M
$13.4M
FCF Margin
CLB
CLB
KRT
KRT
Q1 26
0.4%
Q4 25
3.6%
13.1%
Q3 25
4.8%
0.6%
Q2 25
8.0%
7.7%
Q1 25
3.1%
7.4%
Q4 24
13.4%
7.9%
Q3 24
7.7%
17.0%
Q2 24
10.9%
11.9%
Capex Intensity
CLB
CLB
KRT
KRT
Q1 26
Q4 25
2.1%
0.2%
Q3 25
1.5%
0.2%
Q2 25
2.7%
0.1%
Q1 25
2.3%
0.1%
Q4 24
2.5%
0.2%
Q3 24
2.0%
0.3%
Q2 24
2.2%
0.2%
Cash Conversion
CLB
CLB
KRT
KRT
Q1 26
0.77×
Q4 25
1.61×
2.26×
Q3 25
0.60×
0.13×
Q2 25
1.31×
0.89×
Q1 25
1.21×
Q4 24
2.78×
1.47×
Q3 24
1.12×
2.14×
Q2 24
1.90×
1.50×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons